Table 3.
First author | Year | Population | Intervention | Duration | Main outcome | Evidence level | Conclusion |
---|---|---|---|---|---|---|---|
RCTs Ghanwat and Sontakke [23] |
2019 | Adults with WC ≥80/90 cm | Vitamin C 500 mg 3/d | 3 months | FBG, insulin, HOMA-IR, and QUICKI | Level 2 | Improvement in FBG, insulin, HOMA-IR, and QUICKI |
| |||||||
Romain et al. [24] | 2021 | Adults with BMI 25–40 kg/m2 | Flavonoid and vitamin B3-rich extract versus placebo | 16 weeks | BW, WC, BF, health-related QoL | Level 2 | Improvements in BW, WC, and BF, physical health QoL |
| |||||||
Rohling et al. [41] | 2021 | Adults with BMI 27–35 kg/m2 and w/> 1 component of metabolic syndrome | Meal replacement by formula diet versus lifestyle | 52 weeks | BW | Level 2 | 12 weeks: meal replacement linked to larger BW (-2.39 kg) 52 weeks: no difference |
| |||||||
Halle [42] | 2020 | Adults with BMI 27–35 kg/m2 and w/> 1 component of metabolic syndrome | Meal replacement by formula diet versus lifestyle | 52 weeks | FM, FFM, WC, FBG, SBP, DBP, TC, HDL-c, LDL-c, TG | Level 2 | Improvements in all parameters |
| |||||||
Lowe et al. [53] | 2020 | Adults with BMI 27–43 kg/m2 | Time-restricted eating (16:8 h) | 12 weeks | BW, FM, LM, insulin, FBG, HbA1c | Level 2 | No evidence of difference |
| |||||||
Hassapidou et al. [31] | 2020 | Adults with BMI ≥25 kg/m2 | MED versus usual care | 6 months | BW, WC, HC, % BF | Level 2 | Weight loss only in the intervention group |
| |||||||
Headland et al. [51] | 2019 | Adults with BMI ≥25 kg/m2 | IF versus CER | 12 months | BW, body composition, TC, HDL-c, LDL-c, TG, FBG | Level 2 | No difference in any parameter |
| |||||||
Brown et al. [45] | 2020 | Adults with T2DM (insulin) and obesity | Low-energy total meal replacement | 12 months | BW, HbA1c, FBG, C-peptide, serum lipids, BP, body composition, and QoL | Level 2 | Improved BW, HbA1c, insulin dosage, QoL |
| |||||||
Gajewska [81] | 2019 | Adults with BMI ≥25 kg/m2 and hypertension | Nutrition education individual versus group | 6 months | BW, WC, BP, FBG, OGTT, HOMA-IR, lipids | Level 2 | Better BW, WC, BP, OGTT, HOMA-IR with individual education |
| |||||||
Sundfør et al. [52] | 2019 | Adults with BMI 30–45 kg/m2 and w/> 1 component of metabolic syndrome | IER versus CER | 3 months | BW, energy intake | Level 2 | No differences in BW Better dietary habits with CER |
| |||||||
Cai et al. [32] | 2019 | Adults >60 y with BMI ≥28 kg/m2 | Community intervention versus usual care | 24 months | BW, WC, BP, FBG, TC, HDL-c, LDL-c, TG | Level 2 | Community intervention linked to improved BW, WC, SBP, TG, HDL-c |
| |||||||
Gepner et al. [35] | 2019 | Adults with WC ≥88/102 cm or TG≥150 mg/dL and HDL-c <40 mg/dL/<50 mg/dL | MED versus low-fat diet | 18 months | BW, WC, FBG, insulin, TC, LDL-c, HDL-c, TG, HOMA-IR, hepatic fat content | Level 2 | MED reduced hepatic fat content, TG, HDL-c, DBP further than low-fat diet |
| |||||||
Mitra [82] | 2019 | Adults with BMI ≥23 kg/m2 | High-protein, vit E, and fibre, energy-restricted diet versus usual care | 6 months | BW, WC, HC, FM, FFM, TC, TG, HDL-c, FBG, insulin, CRP, HOMA-IR | Level 2 | The intervention led to significant improvements in BW, WC, FM, insulin, HOMA-IR, CRP |
| |||||||
Otten [83] | 2019 | Postmenopausal women with BMI 27–41 kg/m2 | Paleolithic dietary pattern versus Nordic diet | 2 years | BW, FM, OGTT, Glucagon, GLP-1, GIP | 1A large | Paleolithic diet superior to Nordic in BW, FM, and GLP-1 |
| |||||||
Salas-Salvado et al. [36] | 2019 | Adults with BMI 27–40 kg/m2 and metabolic syndrome | MED and physical activity weight loss intervention versus MED alone | 12 months | BW, WC, FM, FFM, FBG, HOMA-IR, DBP, SBP, HbA1c, TG, TC, HDL-c, CRP, IL, TNF-α | 1A large | Intensive MED intervention led to further improvements in BW, WC, insulin, FBG, HOMA-IR, blood lipids |
| |||||||
Ilich et al. [25] | 2019 | Postmenopausal women with 26–45 kg/m2 | Calcium (1.5 g/d) and vitamin D (600 IU/d) via foods or supplements | 6 months | BW, WC, HC, FM, LM, BMD | Level 2 | Calcium and vitamin D supplementation through food associated with better BW and FM |
| |||||||
Weaver [84] | 2019 | Adults >65 y with BMI ≥30 kg/m2 | Hypocaloric diet with 1 g/kg BW protein versus normocaloric 0.8 g/kg BW protein | 6 months | BW, BMD | 1A large | BW changes only in intervention without differences in bone density |
| |||||||
Higgins [85] | 2019 | Adults with BMI ≥25 kg/m2 | Sucrose, aspartame, saccharin, sucralose, rebaudioside A | 12 weeks | BW, FM, FFM, OGTT | Level 2 | Sucrose and saccharin led to increased BW Sucralose associated with BW reduction No impact on OGTT |
| |||||||
Phelan et al. [44] | 2018 | Women at 9–16 weeks gestation with pregestation BMI ≥25 kg/m2 | Partial meal replacement versus usual care | 26 weeks | Gestational weight gain | Level 2 | Partial meal replacement linked with better adherence to gestational weight gain guidelines |
| |||||||
Guo et al. [43] | 2018 | Adults with BMI >24 kg/m2 | Meal replacement versus routine diet | 12 weeks | BW, WC, HC, FFM, FM, SBP, DBP, TC, TG, HDL-c, FBG | Level 2 | Meal replacements were associated with greater improvements in BW, WC, FFM, FM, and FBG |
| |||||||
Watson [86] | 2018 | Adults with BMI ≥25 kg/m2 and T2DM | High-protein versus high-carbohydrate dietary patterns | 24 weeks | BW, WC Psychological wellbeing, QoL, sleep | Level 2 | High-protein diets expand the positive impact of weight loss on general health and vitality |
| |||||||
Madjd [87] | 2018 | Adult women with overweight or obesity | Replacing low-calorie sweetened beverages with water | Weight loss, BMI, HOMA-IR, 2-h postprandial glucose | Level 2 | Replacement of low-calorie sweetened beverages with water after the main meal in women who were regular users of low-calorie sweetened beverages may cause further weight reduction during a 12-month weight maintenance programme. It may also offer benefits in carbohydrate metabolism including improvement of insulin resistance over the long-term weight maintenance period | |
| |||||||
Gorostegi-Anduaga [88] | 2018 | Adults with overweight and obesity with primary hypertension and are sedentary | Aerobic exercise and nutritional intervention | Cardiovascular risk scores and vascular age | Level 2 | The improvement in CVR factors after 16-week lifestyle changes reduced the risk of suffering a cardiovascular event in adults with overweight/obesity with HTN through the FRS estimation tool but not with the ASCVD score. The risk score algorithms could underestimate CVR in women. In contrast, VA could be a useful and easier tool in the management of individuals with CVRfactors | |
| |||||||
Kahleova [89] | 2018 | Adults with overweight or obesity | Plant-based high-carbohydrate, low-fat (vegan) dietary pattern or to maintain their current dietary pattern | A linear regression model was used to test the relationship between carbohydrate intake and body composition and insulin resistance | 1A large | Results suggest encouraging a flexible approach to eating behaviour and discouraging rigid adherence to a dietary pattern may lead to better intentional weight loss for older women with overweight and obesity | |
| |||||||
Berg [90] | 2018 | Older women with overweight or obesity | Flexible eating behaviour following a diet and exercise intervention | Weight loss | Level 2 | ||
| |||||||
Dus-Zuchowska et al. [37] | 2018 | Postmenopausal women with obesity and a high risk of metabolic syndrome | CED could be an alternative to the MED | CRP and asymmetrical dimethylarginine | Level 2 | In the central European postmenopausal women with obesity population, a well-designed, energy-restricted diet with the use of food items traditional for the region (CED) could be a good alternative to MED in terms of AT prevention | |
| |||||||
Kikuchi [91] | 2018 | Japanese adults with visceral fat obesity | Refined wheat bread versus whole grain wheat bread | BW, BMI, WC, VFA, lipids, BP, diabetes measures | Level 2 | The WW group showed decrease (–4 cm2) in VFA (p < 0.05), whereas the RW group showed no significant changes. These time-dependent changes were significantly different between the groups. WW diet led to significant and safe reductions in VFA in subjects with BMI ≥23 kg/m2. WW diet may contribute to preventing visceral fat obesity | |
| |||||||
Höchsmann et al. [33] | 2021 | Adults with obesity | Primary care: ILI | FBG and lipids, SBP, DBP, metabolic syndrome severity | Level 2 | A pragmatic ILI consistent with national guidelines and delivered by trained health coaches in primary care produced clinically relevant improvements in cardiometabolic health in an underserved population over 24 months | |
| |||||||
Miller et al. [29] | 2021 | Adults 50–75 years old BMI ≥25 kg/m2 with T2DM | Whey protein (40 g/d) + vit D3 (2000 IU/d) combined with exercise versus exercise alone (n = 198) | 24 weeks | HbA1c, HOMA2-IR, FBG Body composition, BP, lipid profile, inflammatory markers | Level 2 | No effect on body composition, HbA1c, HOMA2-IR Improved FBG |
| |||||||
Haghighat [92] | 2020 | Women with BMI between 18.5 and 24.9 kg/m2 and an excess in BF% >33.3% | Euengetic high protein versus standard protein | Appetite and body composition | 1A large | ||
| |||||||
Aparecida Silveira [93] | 2020 | Adults with sarcopenia and severe obesity | EVOO and/or the traditional Brazilian diet | Level 2 | DieTBra contributes to improvements in handgrip strength, walking speed, and total BF in adults with obesity (BMI >40 kg/m2) | ||
| |||||||
Lison [94] | 2020 | Patients with obesity and hypertension | Web-based exercise and nutritional education | BMI (primary outcome), FM, SBP, DBP, FBG, insulin, physical activity levels, and functional capacity for aerobic exercise | Level 2 | ||
| |||||||
Rakvaag et al. [30] | 2019 | Adults with abdominal obesity (n = 65) | Whey protein (60 g/d) combined with wheat bran (30 g/d) | 12 weeks | Fasting and postprandial lipid profiles | 1A large | Whey protein increased fasting TC with or without wheat bran Whey protein improved TG only without wheat bran |
| |||||||
Yari [95] | 2020 | Adults with overweight or obesity | Flaxseed | Anthropometric measurements, lipid profile, HOMA-IR, and inflammatory biomarkers | Level 2 | ||
| |||||||
Meta-analysis or systematic review of high-quality RCT | |||||||
Qu et al. [28] | 2021 | Adults BMI ≥25 kg/m2 |
Prebiotics supplements versus Placebo | BMI, BW, WC CRP, TN-a, IL-1β, LPS | Level 1a (meta-analysis) | No difference in adiposity parameters Improvements in inflammatory markets | |
| |||||||
Enriquez Guerrero [96] | 2021 | Adult population (18–70 years old) with BMI ≥25 kg/ m2 | IF versus CER | BMI, BW, WC, FM TC, HDL-c, LDL-c, TG | Level 1a (meta-analysis) | IF showed higher weight loss and higher FM reduction but similar WC reduction IF improved lipid profile, but evidence is less conclusive | |
| |||||||
Willems [97] | 2021 | Adults with obesity | Low-carbohydrate and low-fat dietary patterns | Markers of the metabolic syndrome | Level 2 | Higher fat and protein intakes associated with improved markers of MetS | |
| |||||||
Park et al. [46] | 2020 | Adults BMI ≥25 kg/m2 |
ADF | BMI, BW, WC, FM, and LM TC, TG, HDL-c, LDL-c, FBG, insulin, HOMA-IR, CRP, SBP, and DBP | Level 1a | ADF effectively lowers BMI, BW, FM, and TC in adults with BMI ≥25–29.9 kg/m2 in interventions <6 months compared to control ADF lowers WC in adults with BMI ≥30 kg/m2, ≥40 years old | |
| |||||||
Yan et al. [47] | 2020 | Adults with overweight or obesity | Fasting | BW, BMI, FFM, FM, WC, TC, LDL-c, HDL-c, TG, SBP, DBP, FBG, insulin | Level 1a | Our meta-analysis found that fasting was associated with a significant effect on the regulation of anthropometric (BW, BMI, FEM, FM, and WC) and metabolic parameters (LDL-C, TG, SBP, and DBP) in people with overweight or obesity | |
| |||||||
Maula et al. [39] | 2020 | Adults with overweight or obesity and type 2 diabetes | Educational weight loss interventions | BW and BMI change | Level 1a | Low-calorie, low-carbohydrate meal replacements or dietary patterns combined with education appear the most promising interventions to achieve the largest weight and BMI reductions in people with type 2 diabetes | |
| |||||||
Wang [98] | 2020 | Adults with overweight or obesity | Whole grain foods | Cardiovascular risk outcomes | Level 1a | This study suggests that whole grain food consumption can slightly reduce BW and CRP in people with overweight/obesity | |
| |||||||
Mu [99] | 2019 | Asian women (non-menopausal) with overweight or obesity | Soy products | BW, BMI, % BF, FM, WC | Level 1a | This meta-analysis showed that soy products have weight loss effects, mainly due to soy protein, isoflavone, and soy fibre | |
| |||||||
Suzumura et al. [27] | 2019 | Adults with overweight or obesity | Oral supplementation with probiotics or symbiotics | BW, BMI, WC | Level 1a | oral supplementation with probiotics or symbiotics has a small effect on WC reduction but no effect on BW or BMI Low to moderate quality of evidence | |
| |||||||
Roman et al. [50] | 2019 | Adults with overweight or obesity | Intermittent versus continuous fasting | BW, BF, LM, WC, HC, and energy expenditure (kJ/day) | Level 1a | This systematic review in individuals with overweight and obesity showed that regular IF decreased LM compared to continuous fasting. There were no differences in effects for either intermittent versus continuous interventions across all other outcomes | |
| |||||||
Bassatne et al. [26] | 2019 | Adults with obesity | Vitamin D supplementation | BMD, extra-skeletal parameters | Level 2 | No clear evidence for a beneficial effect of vitamin D supplementation on cardiometabolic parameters in adults living with obesity | |
| |||||||
Gjuladin-Hellon [100] | 2019 | Adults BMI ≥25 kg/m2 | Very low- and low-carbohydrate dietary patterns versus low-fat dietary patterns | TC, TG, HDL-c, LDL-c | Level 1a (meta-analysis) | Carbohydrate restriction is superior to fat restriction in improving lipid profile | |
| |||||||
Astbury et al. [40] | 2019 | Adults with overweight or obesity | Meal replacements | Weight loss | Level 1a | Programmes incorporating meal replacements led to greater weight loss at 1 year than comparator weight loss programmes and should be considered as a valid option for management of overweight and obesity in community and healthcare settings | |
| |||||||
Booth [101] | 2018 | Adults with overweight or obesity | Diet-induced weight loss | Psychological stress | Level 1a | ||
| |||||||
Castellana [102] | 2020 | Adults with overweight or obesity | VLCKD | BW, BMI, WC, body composition, BP, HbA1c, lipids, and markers of liver and kidney function | Level 1a | VLCKD proved to be a reliable option to achieve a significant weight loss in patients with overweight and obesity. Results were early obtained during the ketogenic phase and were stable over a follow-up of up to two years. In addition, VLCKD was associated with significant improvements in comorbidities, including hypertension, dyslipidaemia, T2DM, and NAFLD. However, an increase in serum sodium was found. VLCKD should thus be regarded as an effective intervention to be proposed to properly selected patients, as a part of a multicomponent strategy, and under strict medical supervision | |
| |||||||
Noronha et al. [38] | 2019 | Adults with overweight or obesity and T2D | Liquid meal replacements | Cardiometabolic risk factors | Level 1a | Liquid meal replacements in weight loss diets lead to modest reductions in BW, BMI, and SBP and reductions of marginal clinical significance in BF, WC, HbA1c, fasting glucose, fasting insulin, and DBP | |
| |||||||
Cheng [103] | 2018 | Postmenopausal women with obesity | Nutrition and exercise interventions | BW, BMI, WC, FM, LM | Level 1a (meta-analysis) | Diet and exercise combined results in greater weight loss, FM, and LM loss Diet alone leads to greater weight loss than exercise alone | |
| |||||||
Jovanovski [104] | 2021 | Adults BMI ≥25 kg/m2 | Viscous fibre supplementation in calorie-restricted dietary pattern | BW, BMI, WC, BF | Level 1a (meta-analysis) | Moderate evidence for reduced BW, BMI, and BF Low evidence for reduced WC |
|
| |||||||
Vitale and Kim [49] | 2020 | Adults with obesity and T2DM | IF | BW and glycaemic control | Level 1a (systematic review) | Insignificant differences between IF and CER on glycated haemoglobin A1c and body composition | |
| |||||||
Canuto et al. [34] | 2021 | Adults with overweight and obesity | Primary care interventions | Weight reduction | Level 3 (meta-analysis) | No impact of diet alone or combined approaches on weight loss Similar findings for individual versus group sessions | |
| |||||||
Churuangsuk [105] | 2018 | Adults with overweight or obesity | Low-carb dietary patterns | Weight loss | Level 3 (review of reviews) | Little or no difference in weight loss with low-carb dietary patterns versus control |
TD2M, type 2 diabetes mellitus; BMI, body mass index; WC, waist circumference; HC, hip circumference; BF, body fat; BW, body weight; FM, fat mass; LM, lean mass; FFM, fat free mass; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TG, triglyceride; CRP, C-reactive protein; TN-a, tumour necrosis factor alpha; IL-1β, interleukin 1β; LPS, lipopolysaccharide; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HOMA-IR, homeostatic model assessment for insulin resistance; HbA1c, glycated haemoglobin; OGTT, oral glucose tolerance test; BMD, bone mineral density; ILI, intensive lifestyle intervention; EVOO, extra virgin olive oil; IER, intermittent energy restriction; CED, Central European diet; VFA, visceral fat area. ADF, alternate day fasting; VLCKD, very low-calorie ketogenic diet.